About Us
Launched on September 2022, ADVANCE-TB COST Action (CA21164) aims to address the complexity of tuberculosis (TB) management. ADVANCE-TB is a research network that offers opportunities for collaboration between clinicians, academic researchers from interdisciplinary backgrounds, industry and non-governmental organizations with the aim of advancing TB research.
This is us
Passionate. Committed. Positive.
ADVANCE-TB has more than 250 members coming from 47 different countries worldwide and we keep growing. So far we have 67 members in Working Group (WG) 1, 147 in WG2, 133 in WG3 and 66 in WG4. Our Management Committee consists of 43 members from 24 countries.
The following are the 9 members with leading roles. Feel free to contact them!
Action Chair
Dr. Alicia Lacoma
Institut Germans Trias i Pujol, Consorcio de Investigación Biomédica en Red Enfermedades Respiratorias (CIBERES), Spain.
0034 93 554 3050; Extension 6501
Grant Holder Scientific Representative
Dr. José Domínguez Benítez
Institut d'Investigació Germans Trias i Pujol, Spain
Science Communication Coordinator and WG4 Leader
Dr. Mateja Jankovic Makek
University Hospital Center Zagreb, Croatia
Grant Awarding Coordinator
Dr. Cristina Prat Aymerich
European Clinical Research Alliance on Infectious Diseases. Julius Center for Health Sciences and Primary Care, University Medical Centre Utrecht, Utrecht University, the Netherlands.
WG1 Leader
Dr. Zorica Nanovic
Institute of Lung Diseases and Tuberculosis, Skopje. State University "Goce Delchev" Stip, North Macedonia
WG3 Leader
Dr. Martina Hrast Rambaher
University of Ljubljana, Faculty of Pharmacy, Slovenia
Would you like to join us?
-
Read the Project Description Memorandum of Understanding.
-
Inform the Chair of ADVANCE-TB, Alicia Lacoma, by email.
-
Apply to join your Working Group(s) of interest.